Lol 2 billion. Current Inventory of leronlimab alone could be worth that, who knows when the next pandemic will be but i believe Leronlimab’s moa would be one of the best positioned to fight it along with 30+ indications. First eua or approval 5-10billion. After that should jump up immensely on further indications or buyout value